企业简介_南京普济生物

Company Overview Development History qualification & certification Cultural Concept Social Responsibility Partner

Pregene Biotechnology

Pregene Biotechnology is an innovative biotechnology enterprise with full-chain independent innovation technology as its core and integrating next-generation molecular diagnostic instruments, reagents, and medical testing services.
The company holds a number of national and international patents and is a provider ofNeoHiT® PCR clinical diagnostic solutions covering the three major fields of tumor diagnosis and treatment, reproductive health, and pathogen detection.

Bottom-level Innovation

Based on unmet clinical needs, we carry out disruptive innovation in the underlying technology platform and are committed to becoming the mainstream methodology of molecular diagnosis; we createNeoHiT® PCR clinical diagnostic solutions to solve the long-term core pain points of the molecular diagnostic industry.

Technical Advantages

Pregene Biotechnology is a global pioneer in NeoHiT® PCR technology. The innovative NeoHiT® PCR system includes NeoHiT® PCR technology and fluorescence encoding technology, which has the dual advantages of large amount of detection information and high detection sensitivity; breaking through the traditional PCR detection signal Order of magnitude, solving the long-term core pain points of the molecular diagnostic industry and having extremely high barriers.

发展潜力

Starting from clinical needs, Pregene Biotechnology has created a next-generation molecular diagnostic platform that is "more, faster, better and more economical", which can easily, quickly and economically realize clinical applications that originally required complex equipment; taking into account timeliness and cost, it supports IVD admission and Popularize and sink to empower clinical practice.

Company Strength

The company was founded by a team of returned scientists. The core team has comprehensive backgrounds in management, R&D, registration, clinical and sales. Most of the team members come from key universities at home and abroad, with nearly 70% of them having master's or doctoral degrees. The company is headquartered in one of the country's first-class high-end medical devices and The new drug production base - Nanjing Jiangbei New District Biomedical Valley, covers an area of nearly 8,000 square meters, of which 4,000 square meters are GMP standardized factory buildings.

Development History

2003

The founding team independently started underlying technology research and development in the Bay Area of the United States.

2017

Complete third-party instrument adaptation
Started clinical cooperation with Fudan Zhongshan Hospital and Red House Hospital

2019

Obtained the first batch of clinical verification data
Early entrepreneurial teams tend to be complete

2020

Landed in Nanjing Jiangbei New District Medicine Valley
1,200 square meters laboratory completed

2021

Completed a new round of financing
Jiangsu Province Private Technology Enterprise
The team gradually matures and the NeoHiT® PCR system is fully independently developed.

2022

Tendering for top tertiary hospitals comes to fruition
Establishment of ISO13485 and ISO15189 systems
7,300 square meters GMP+ICL completed
Jiangsu Province Mass Entrepreneurship Talent Plan

2023

The NeoHiT® PCR platform obtained a complete medical device registration certificate, and multiple Class III certificate kits completed registration inspection
Several benchmark tertiary hospitals have been established
Completed a new round of financing
National High-Tech Enterprise
Technology-based small and medium-sized enterprises
Innovative small and medium-sized enterprises

Future

2003

The underlying technology begins to be developed

2017

Start sample verification

2019

Founded

2020

Officially launched

2021

hone inner strength

2022

First show of strength

2023

Jump out of the water

Future

The future is promising

qualification & certification

38items

Intellectual property rights
12items

临床研究
5items

国际专利(持续申请中)
2

Registration phase products
6items

Copyright
11

Medical device registration certificate

Cultural Concept

Corporate Vision

In response to unmet clinical needs, we continue to carry out product technology innovation and service upgrades to become the world's leading provider of molecular diagnostic solutions.
Our Mission

We are committed to reshaping the industry through revolutionary underlying innovation and developing molecular diagnostics that benefit everyone in the world.
Core Value

Cooperation, responsibility, quality, innovation

Social Responsibility

Use technological progress to promote cutting-edge products to benefit the people.

Sustainable development strategy

Pregene Biotechnology focuses on the protection and improvement of the ecological environment. Whether it is product research and development, production or company activities, we actively respond to the global environmental protection needs for energy conservation and emission reduction, and implement the concept of sustainable development into corporate development.
Charitable Activities

While promoting the healthy development of the enterprise, Pregene Biotechnology focuses on key areas of social responsibility such as medical and health care, culture and education, and engages in various public welfare undertakings, striving to benefit people's livelihood and give back to society with its development results.
People Oriented

Pregene Biotechnology adheres to the people-oriented concept, pays attention to the protection of employees' rights and interests and career development, creates a good working environment for employees, strives to benefit every employee from the company's development results, and promotes the harmonious development of the enterprise.
Sustainable Supply Chain

The supply chain is an important link in corporate operations. Pregene Biotechnology improves the operational efficiency of the company's existing business through management optimization, equipment upgrades and process transformation, thereby promoting energy conservation and emission reduction to achieve new business growth.